Cognyte Software Ltd. (CGNT)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cognyte Software Ltd. (“Cognyte” or “the Company”) (NASDAQ: CGNT). Investors who purchased Cognyte securities are encouraged to obtain additional information and assist the investigation.

The investigation concerns whether Cognyte and certain of its officers and/or directors have violated federal securities laws.

On June 28, 2022, Cognyte issued a press release announcing its financial results for the Company’s first fiscal quarter of 2022. Among other items, Cognyte reported revenue of $86.7 million, missing consensus estimates by $25.9 million. Cognyte said that its results were “impacted by slow pipeline conversion and supply chain” and said that the Company was “unable to give guidance” at that time. On this news, Cognyte’s stock price fell sharply during intraday trading on June 28, 2022.

If you are aware of any facts relating to this investigation or purchased Cognyte shares you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.